Therapeutic concentrations of cyclosporine A, but not FK506, increase P- glycoprotein expression in endothelial and renal tubule cells

Kidney International

Volumn 54, Issue 4, 1998, Pages 1139-1149

  Hauser, Ingeborg A ^b   Koziolek, Michael ^b   Hopfer, Ulrich ^b   Thévenod, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

C219; Immunosuppressive drugs; MDR1; MRK 16; Nephrotoxicity; Rejection therapy; Xenobiotics

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; TACROLIMUS;

ARTICLE; BLOOD BRAIN BARRIER; CELL DAMAGE; CONCENTRATION RESPONSE; DEPHOSPHORYLATION; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KIDNEY TUBULE CELL; MULTIDRUG RESISTANCE; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031658439     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00095.x     Document Type: Article

References (41)

1. GOTTESMAN MM, PASTAN I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427, 1993
2. RONINSON IB: The role of the MDRI (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol 43:95-102, 1992
3. THIEBAUT F, TSURUO T, HAMADA H, GOTTESMAN MM, PASTAN I, WILLINGHAM MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738, 1987
4. CORDON-CARDO C, O'BRIEN JP, CASALS D, RITTMAN-GRAUER L, BIEDLER JL, MELAMED MR, BERTINO JR: Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698, 1989
5. SCHINKEL AH, SMIT JJ, VAN TELLINGEN O, BEIJNEN JH, WAGENAAR E, VAN DEEMTER L, MOL CA, VAN DER VALK MA, ROBANUS-MAANDAG EC, TE RIELE HP, BERNS AJM, BORST P: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502, 1994
6. SCHINKEL AH, WAGENAAR E, VAN DEEMTER L, MOL CA, BORST P: Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698-1705, 1995
7. SAEKI T, UEDA K, TANIGAWARA Y, HORI R, KOMANO T: Human P-glycoprotein transports cyclosporine A and FK506. J Biol Chem 268:6077-6080, 1993
8. LIU J, FARMER JD JR, LANE WS, FRIEDMAN J, WEISSMAN I, SCHREIBER SL: Calcineurin is a common target of cyclophilin-cyclosporine A and FKBP-FK506 complexes. Cell 66:807-815, 1991
9. TAKAHASHI N, HAYANO T, SUZUKI M: Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337:473-475, 1989
10. FISCHER G, WITTMANN-LIEBOLD B, LANG K, KIEFHABER T, SCHMID FX: Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476-478, 1989
11. BIERER BE, SOMERS PK, WANDLESS TJ, BURAKOFF SJ, SCHREIBER-SL: Probing immunosuppressant action with a nonnatural immunophilin ligand. Science 250:556-559, 1990
12. JAIN AB, FUNG JJ, VENKATARAMANAN R, TODO S, ALESSIANI M, STARZL TE: FK 506 dosage in human organ transplantation. Transplant Proc 22:23-24, 1990
13. JORDAN ML, NARAGHI R, SHAPIRO R, SMITH D, VIVAS CA, SCANTLEBURY VP, GRITSCH HA, MCCAULEY J, RANDHAWA P, DEMETRIS AJ, MCMICHAEL J, FUNG JJ, STARZL TE: Tacrolimus rescue therapy for renal allograft rejection: Five-year experience. Transplantation 63: 223-228, 1997
14. RANDHAWA PS, SHAPIRO R, JORDAN ML, STARZL TE, DEMETRIS AJ: The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol 17:60-68, 1493
15. VINCENTI F, LASKOW DA, NEYLAN JF, MENDEZ R, MATAS AJ: One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. Transplantation 61:1576-158, 1996
16. MIHATSCH MJ, ANTONOVYCH T, BOHMAN SO, HABIB R, HELMCHEN U, NOEL LM, OLSEN S, SIBLEY RK, KEMENY E, FEUTRIN G: Cyclosporin A nephropathy: Standardization of the evaluation of kidney biopsies. Clin Nephrol 41:23-32, 1994
17. MOROZUMI K, SUGITO K, ODA A, TAKEUCHI O, FUKUDA M, USAMI T, OIKAWA T, FUJINAMI T, KOYAMA K, TAKEDA A, YOSHIDA A, HABA T, TOMINAGA Y, UCHIDA K, YOKOYAMA I, TAKAGI H: A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: Are the morphologic characteristics of FK506 and CyA nephrotoxicity similar? Transplant Proc 28:1076-1078, 1996
18. ANDOH TF, BURDMANN EA, BENNETT WM: Nephrotoxicity of immunosuppressive drugs: Experimental and clinical observations. Semin Nephrol 17:34-45, 1997
19. HERZOG CE, TSOKOS M, BATES SE, FOJO AT: Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem 268:2946-2952, 1993
20. JETTÉ BEAULIEU E, LECLERC J-M, BÉLIVEAU R: Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am J Physiol 270:F756-F765, 1996
21. +)-ATPase alpha-subunit in Drosophila melanogaster. EMBO J 8:193-202, 1989
22. HAUSER IA, JOHNSON DR, MADRI JA: Differential induction of VCAM-I on human iliac venous and arterial endothelial cells and its role in adhesion. J Immunol 151:5172-5185, 1993
23. WOOST PG, OROSZ DE, JIN W, FRISA PS, JACOBBERGER JW, DOUGLAS JG, HOPFER U: Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidnev Int 50:125-134, 1996
24. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
25. THÉVENOD F, HILDEBRANDT JP, STRIESSNIG J, DEJONGE HR, SCHNULZ I: Chloride and potassium conductances of mouse pancreatic zymogen granules are inversely regulated by a ∼80-kDa mdr1a gene product. J Biol Chem 271:3300-3305, 1996
26. LAEMMLI UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
27. HOMOLYA L, HOLLO Z, GERMANN UA, PASTAN I, GOTTESMAN MM, SARKADI B: Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493-21496, 1993
28. KARTNER N, EVERNDEN-PORELLE D, BRADLEY G, LING V: Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316:820-823, 1985
29. GLORGES E, BRADLEY G, GARIEPY J, LING V: Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc Natl Acad Sci USA 87:152-156, 1990
30. GEORGES E, TSURUO T, LING V: Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. J Biol Chem 268:1792-1798, 1993
31. FORD JM, HAIT WN: Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155-199, 1990
32. JAKOB I, HAUSER IA, THÉVENOD F, LINDEMANN B: MDR1 in taste buds of rat vallate papilla: Functional, immunohistochemical and biochemical evidence. Am J Physiol 274:C182-C191, 1998
33. TAMAI I, SAFA AR: Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. J Biol Chem 265:16509-16513, 1990
34. THÉVENOD F, HERAK-KRAMBERGER C, SABOLIC I: The expression of multidrug resistance P-glycoprotein (mdr1) increases along kidney proximal tubule (PT), and its distribution inverses in cadmium (Cd)-intoxicated rats. (abstract) FASEB J 11:A460, 1997
35. VENKATARAMANAN R, JAIN A, WARTY VS, ABU-ELMAGD K, ALESSIANI M, LEVER J, KRAJAK A, FLOWERS J, MEHTA S, ZUCKERMAN S, FUNG J, TODO S, STARZL TD: Pharmacokinetics of FK 506 in transplant patients. Transplant Proc 23:2736-2740, 1991
36. WOOD AJ, MAURER G, NIEDERBERGER W, BEVERIDGE T: Cyclosporine: Pharmacokinetics, metabolism and drug interactions. Transplant Proc 15:2409-2412, 1983
37. GARCIA DEL MORAL R, O'VALLE F, ANDUJAR M, AGUILAR M, LUCENA MA, LOPEZ-HIDALGO J, RAMIREZ C, MEDINA-CANO MT, AGUILAR D, GOMEZ-MORALES M: Relationship between P-glycoprotein expression and cyclosporine A in kidney. An immunohistological and cell culture study. Am J Pathol 146:398-408, 1995
38. KEMNITZ J, UYSAL A, HAVERICH A, HEUBLEIN B, COHNERT TR, STANGEL W, GEORGII A: Multidrug resistance in heart transplant patients: A preliminary communication on a possible mechanism of therapy-resistant rejection. J Heart Lung Transplant 10:201-210, 1991
39. ZANKER B, BARTH, C, MENGES AV, LAMMERDING P, STACHOWSKI J, BALDAMUS CA: Expression of the multidrug resistance gene MDR-1 in peripheral blood mononuclear cells from cyclosporine-treated renal transplant recipients rejecting their graft. Transplant Proc 27:925-926, 1995
40. ZANKER B, BARTH C, STACHOWSKI J, BALDAMUS CA, LAND W: Multidrug resistance gene MDR1 expression: A gene transfection in vitro model and clinical analysis in cyclosporine-treated patients rejecting their renal grafts. Transplant Proc 29:1507-1508, 1997
41. BENNETT WM, DEMATTOS A, MEYER MM, ANDOH T, BARRY JM: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996